Lakefront Biotherapeutics Announces ASH Poster Presentation
The company says gamgertamig data from ongoing Phase 1b studies suggest potential to retain remission after B cell re...
The company says gamgertamig data from ongoing Phase 1b studies suggest potential to retain remission after B cell re...